Rang	Name	Position
1	Dr. N. Anthony Coles Jr., M.P.H.	Executive Chairman
2	Mr. Ronald C. Renaud Jr., M.B.A.	President, CEO & Director
3	Dr. Susan Altschuller M.B.A., Ph.D.	Chief Financial Officer
4	Mr. Mark Bodenrader	Senior VP of Finance & Chief Accounting Officer
5	Dr. John J. Renger Ph.D.	Chief Scientific Officer
6	Dr. Ramiro Sanchez M.D.	Chief Medical Officer
7	Mr. Paul D. Burgess J.D.	Chief Business Development & Strategic Operations Officer
8	Mr. Matthew Calistri	Vice President of Investor Relations
9	Mr. Scott M. Akamine J.D.	Chief Legal Officer & Corporate Secretary
10	Mr. Kenneth A. DiPietro	Chief Human Resources Officer

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	Bain Capital Investors LLC	36,05%	2,95 Mrd. USD
2	Perceptive Advisors LLC	5,92%	0,49 Mrd. USD
3	venBio Select Advisor LLC	4,14%	0,34 Mrd. USD
4	Vanguard Group Inc	3,93%	0,32 Mrd. USD
5	BlackRock Inc	1,95%	0,16 Mrd. USD
6	Fidelity International Ltd	1,78%	0,15 Mrd. USD
7	State Street Corp	1,71%	0,14 Mrd. USD
8	Eckert Corp	1,29%	0,11 Mrd. USD
9	NORGES BANK	1,28%	0,11 Mrd. USD
10	Paradigm Biocapital Advisors LP	1,28%	0,11 Mrd. USD
11	Soros Fund Management LLC	1,18%	0,10 Mrd. USD
12	Millennium Management LLC	1,10%	0,09 Mrd. USD
13	Pentwater Capital Management LP	1,03%	0,08 Mrd. USD
14	Marshall Wace Asset Management Ltd	1,03%	0,08 Mrd. USD
15	AllianceBernstein L.P.	0,82%	0,07 Mrd. USD
16	Geode Capital Management, LLC	0,81%	0,07 Mrd. USD
17	Ameriprise Financial Inc	0,74%	0,06 Mrd. USD
18	Citigroup Inc	0,70%	0,06 Mrd. USD
19	Qube Research & Technologies	0,68%	0,06 Mrd. USD
20	Farallon Capital Management, L.L.C.	0,65%	0,05 Mrd. USD